| pubmed-article:15883332 | rdf:type | pubmed:Citation | lld:pubmed |
| pubmed-article:15883332 | lifeskim:mentions | umls-concept:C0237401 | lld:lifeskim |
| pubmed-article:15883332 | lifeskim:mentions | umls-concept:C0151313 | lld:lifeskim |
| pubmed-article:15883332 | lifeskim:mentions | umls-concept:C0808111 | lld:lifeskim |
| pubmed-article:15883332 | pubmed:issue | 9 | lld:pubmed |
| pubmed-article:15883332 | pubmed:dateCreated | 2005-5-10 | lld:pubmed |
| pubmed-article:15883332 | pubmed:abstractText | We used ELISA to estimate the prevalence of anti-sulfatide antibodies in HIV-infected individuals with distal sensory neuropathy (DSP) and compared the results with the prevalence in HIV-infected individuals without DSP and in individuals with neuropathy who are not infected with HIV. We found that 36% of HIV+/DSP+ individuals had immunoglobulin (Ig) G anti-sulfatide antibody titers greater than 1,500, whereas IgG anti-sulfatide antibodies were rarely found in HIV+/DSP- or HIV-/DSP+ patients. | lld:pubmed |
| pubmed-article:15883332 | pubmed:grant | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:15883332 | pubmed:grant | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:15883332 | pubmed:grant | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:15883332 | pubmed:grant | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:15883332 | pubmed:grant | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:15883332 | pubmed:grant | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:15883332 | pubmed:grant | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:15883332 | pubmed:language | eng | lld:pubmed |
| pubmed-article:15883332 | pubmed:journal | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:15883332 | pubmed:citationSubset | AIM | lld:pubmed |
| pubmed-article:15883332 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:15883332 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:15883332 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:15883332 | pubmed:status | MEDLINE | lld:pubmed |
| pubmed-article:15883332 | pubmed:month | May | lld:pubmed |
| pubmed-article:15883332 | pubmed:issn | 1526-632X | lld:pubmed |
| pubmed-article:15883332 | pubmed:author | pubmed-author:EvansSS | lld:pubmed |
| pubmed-article:15883332 | pubmed:author | pubmed-author:PestronkAA | lld:pubmed |
| pubmed-article:15883332 | pubmed:author | pubmed-author:LORR | lld:pubmed |
| pubmed-article:15883332 | pubmed:author | pubmed-author:CliffordDD | lld:pubmed |
| pubmed-article:15883332 | pubmed:author | pubmed-author:LopateGG | lld:pubmed |
| pubmed-article:15883332 | pubmed:issnType | Electronic | lld:pubmed |
| pubmed-article:15883332 | pubmed:day | 10 | lld:pubmed |
| pubmed-article:15883332 | pubmed:volume | 64 | lld:pubmed |
| pubmed-article:15883332 | pubmed:owner | NLM | lld:pubmed |
| pubmed-article:15883332 | pubmed:authorsComplete | Y | lld:pubmed |
| pubmed-article:15883332 | pubmed:pagination | 1632-4 | lld:pubmed |
| pubmed-article:15883332 | pubmed:dateRevised | 2007-11-14 | lld:pubmed |
| pubmed-article:15883332 | pubmed:meshHeading | pubmed-meshheading:15883332... | lld:pubmed |
| pubmed-article:15883332 | pubmed:meshHeading | pubmed-meshheading:15883332... | lld:pubmed |
| pubmed-article:15883332 | pubmed:meshHeading | pubmed-meshheading:15883332... | lld:pubmed |
| pubmed-article:15883332 | pubmed:meshHeading | pubmed-meshheading:15883332... | lld:pubmed |
| pubmed-article:15883332 | pubmed:meshHeading | pubmed-meshheading:15883332... | lld:pubmed |
| pubmed-article:15883332 | pubmed:meshHeading | pubmed-meshheading:15883332... | lld:pubmed |
| pubmed-article:15883332 | pubmed:meshHeading | pubmed-meshheading:15883332... | lld:pubmed |
| pubmed-article:15883332 | pubmed:meshHeading | pubmed-meshheading:15883332... | lld:pubmed |
| pubmed-article:15883332 | pubmed:meshHeading | pubmed-meshheading:15883332... | lld:pubmed |
| pubmed-article:15883332 | pubmed:meshHeading | pubmed-meshheading:15883332... | lld:pubmed |
| pubmed-article:15883332 | pubmed:year | 2005 | lld:pubmed |
| pubmed-article:15883332 | pubmed:articleTitle | Anti-sulfatide antibodies in HIV-infected individuals with sensory neuropathy. | lld:pubmed |
| pubmed-article:15883332 | pubmed:affiliation | Department of Neurology, Washington University School of Medicine, St. Louis, MO 63110, USA. lopateg@neuro.wustl.edu | lld:pubmed |
| pubmed-article:15883332 | pubmed:publicationType | Journal Article | lld:pubmed |
| pubmed-article:15883332 | pubmed:publicationType | Comparative Study | lld:pubmed |
| pubmed-article:15883332 | pubmed:publicationType | Research Support, U.S. Gov't, P.H.S. | lld:pubmed |
| pubmed-article:15883332 | pubmed:publicationType | Research Support, Non-U.S. Gov't | lld:pubmed |
| pubmed-article:15883332 | pubmed:publicationType | Research Support, N.I.H., Extramural | lld:pubmed |
